“REVIEW OF CURRENT GUIDELINES AND STUDIES ON USE OF ACETYLSALICYLIC ACID IN THE PRIMARY CARDIOVASCULAR EVENTS PREVENTION” (2019) Prospects in Pharmaceutical Sciences, 17(4), pp. 20–23. doi:10.56782/pps.29.